Investment in account receivable (Tables)

6 Months Ended

Jun. 30, 2024

Receivables [Abstract]

Schedule of receivables with imputed interest

The investment in account receivable consists of the following at June 30, 2024 and December 31, 2023:

	June 30, 2024			December 31, 2023
Face value*	$	287,200		$	285,400
Impairment		(250,208	)		-
Total		36,992			285,400
Unamortized discount		(36,992	)		(46,551	)
Net balance		-			238,849
Current portion		-			-
Long term portion	$	-		$	238,849

* Coincident with the impairment, accounts receivable of $2,300 was reclassed and concurrently impaired. Prior to the full impairment, the Company reduced the face value of its investment in account receivable by an additional $100 per month for five receivable payment installments at the six months ended June 30, 2024.